drugset / Trial / NCT05868967
A Clinical Study to Investigate the Mass Balance and Biotransformation of [14C]DWP14012 in Healthy Chinese Male Subjects
Phase 1
Unknown
8 enrolled
Daewoong Pharmaceutical Co. LTD.
Shanghai Haini Pharmaceutical Co., Ltd. · collab
NaSingle-groupOpen-labelOther
Summary
The purpose of this study is to investigate the Mass Balance and Biotransformation of \[14C\]DWP14012 in Healthy Chinese Male Subjects
Timeline
- Start
- 2023-02-27
- Primary completion
- 2023-05-31
- Completion
- 2023-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ABEPRAZAN | Small molecule | 40 mg | Oral |
Indications
No indication recorded.